BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2996602)

  • 1. Activation of the abl oncogene in murine and human leukemias.
    Konopka JB; Witte ON
    Biochim Biophys Acta; 1985 Nov; 823(1):1-17. PubMed ID: 2996602
    [No Abstract]   [Full Text] [Related]  

  • 2. Amino terminal myristylation of the protein kinase p60src, a retroviral transforming protein.
    Schultz AM; Henderson LE; Oroszlan S; Garber EA; Hanafusa H
    Science; 1985 Jan; 227(4685):427-9. PubMed ID: 3917576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human cellular abl gene product in the chronic myelogenous leukemia cell line K562 has an associated tyrosine protein kinase activity.
    Kloetzer W; Kurzrock R; Smith L; Talpaz M; Spiller M; Gutterman J; Arlinghaus R
    Virology; 1985 Jan; 140(2):230-8. PubMed ID: 2982232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functions of the abl oncogene.
    Witte ON
    Cancer Surv; 1986; 5(2):183-97. PubMed ID: 3465440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogene activation by chromosomal translocation in chronic myelocytic leukemia.
    Groffen J; Heisterkamp N; Stam K
    Cold Spring Harb Symp Quant Biol; 1986; 51 Pt 2():911-21. PubMed ID: 3472767
    [No Abstract]   [Full Text] [Related]  

  • 6. An 8-kilobase abl RNA transcript in chronic myelogenous leukemia.
    Gale RP; Canaani E
    Proc Natl Acad Sci U S A; 1984 Sep; 81(18):5648-52. PubMed ID: 6091099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and function of the Abelson murine leukemia virus transforming gene.
    Wang JY; Prywes R; Baltimore D
    Prog Clin Biol Res; 1983; 119():57-63. PubMed ID: 6306691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity.
    Reddy EP; Smith MJ; Srinivasan A
    Proc Natl Acad Sci U S A; 1983 Jun; 80(12):3623-7. PubMed ID: 6304726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of oncogenes in human leukemias.
    McClain KL
    Cancer Res; 1984 Nov; 44(11):5382-9. PubMed ID: 6593118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oncogenes and malignant hemopathies].
    Pogliani EM; Bregani ER; Corneo G
    Recenti Prog Med; 1989 Oct; 80(10):526-30. PubMed ID: 2690219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable expression of the translocated c-abl oncogene in Philadelphia-chromosome-positive B-lymphoid cell lines from chronic myelogenous leukemia patients.
    Konopka JB; Clark S; McLaughlin J; Nitta M; Kato Y; Strife A; Clarkson B; Witte ON
    Proc Natl Acad Sci U S A; 1986 Jun; 83(11):4049-52. PubMed ID: 3012546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the abl oncogene in chronic myelogenous leukemia.
    Mes-Masson AM; Witte ON
    Adv Cancer Res; 1987; 49():53-74. PubMed ID: 3314397
    [No Abstract]   [Full Text] [Related]  

  • 13. TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis.
    Perrotti D; Bonatti S; Trotta R; Martinez R; Skorski T; Salomoni P; Grassilli E; Lozzo RV; Cooper DR; Calabretta B
    EMBO J; 1998 Aug; 17(15):4442-55. PubMed ID: 9687511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substitution of the LTR of Abelson murine leukemia virus does not alter the cell type of virally induced tumors.
    Green PL; Kaehler DA; McKearn J; Risser R
    Oncogene; 1988 Jun; 2(6):585-92. PubMed ID: 2838788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant splicing events that are induced by proviral integration: implications for myb oncogene activation.
    Rosson D; Dugan D; Reddy EP
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3171-5. PubMed ID: 3033638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular genetic aspects of chronic myelocytic leukemia].
    Bartram CR
    Dtsch Med Wochenschr; 1984 Dec; 109(49):1894-900. PubMed ID: 6094139
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor.
    Fichelson S; Vigon I; Dusanter I; Charon M; Velu T; Baillou C; Gisselbrecht S; Lemoine FM
    J Immunol; 1995 Feb; 154(4):1577-86. PubMed ID: 7836743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic analysis of the form and function of the viral src oncogene product.
    Wyke JA; Stoker AW
    Biochim Biophys Acta; 1987 Apr; 907(1):47-69. PubMed ID: 3105582
    [No Abstract]   [Full Text] [Related]  

  • 19. Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.
    Joosten M; Valk PJ; Vankan Y; de Both N; Löwenberg B; Delwel R
    Virology; 2000 Mar; 268(2):308-18. PubMed ID: 10704339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular genetics of cellular oncogenes.
    Varmus HE
    Annu Rev Genet; 1984; 18():553-612. PubMed ID: 6397126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.